Neovasc Inc. Change in payables and accrued liability

Change in payables and accrued liability of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Change in payables and accrued liability growth rates and interactive chart.


Highlights and Quick Summary

  • Change in payables and accrued liability for the quarter ending March 31, 2022 was $-1.28 Million (a -198.58% decrease compared to previous quarter)
  • Year-over-year quarterly Change in payables and accrued liability decreased by -1011.97%
  • Annual Change in payables and accrued liability for 2021 was $-1.99 Million (a 167.46% increase from previous year)
  • Annual Change in payables and accrued liability for 2020 was $-744 Thousand (a -118.32% decrease from previous year)
  • Annual Change in payables and accrued liability for 2019 was $4.06 Million (a 744.57% increase from previous year)
  • Twelve month Change in payables and accrued liability ending March 31, 2022 was $-915 Thousand (a -54.38% decrease compared to previous quarter)
  • Twelve month trailing Change in payables and accrued liability decreased by -56.77% year-over-year
Trailing Change in payables and accrued liability for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-915 Thousand $-2.01 Million $-2.77 Million $-2.12 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Change in payables and accrued liability of Neovasc Inc.

Most recent Change in payables and accrued liabilityof NVCN including historical data for past 10 years.

Interactive Chart of Change in payables and accrued liability of Neovasc Inc.

Neovasc Inc. Change in payables and accrued liability for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-1.28
2021 $1.3 $-1.07 $0.14 $-2.37 $-1.99
2020 $0.54 $-0.42 $0.43 $-1.21 $-0.74
2019 $2.69 $0.67 $0.37 $0.25 $4.06
2018 $0.13 $-0.04 $0.48 $-0.07 $0.48
2017 $-0.47 $-0.2 $0.18 $-0.55 $-1.09
2016 $0.1 $-3.33 $2.32 $0.06 $-0.84
2015 $1.53 $0.3 $0.37 $1.53
2014 $0.82 $0.82

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.